Tag: Androgen deprivation therapy

Clinical studies show that after an initial testosterone surge, Lupron (leuprolide acetate) typically lowers serum testosterone to castrate levels within 2 to 4 weeks [1.2.3, 1.3.1]. This guide details how quickly does Lupron lower testosterone and the mechanisms involved.

Clinical trial data shows that 99% of men on Orgovyx had a rapid drop in testosterone within 15 days. Understanding this response helps track progress and shows how do you know if Orgovyx is working against advanced prostate cancer.

In 2022, an estimated 24,600 men in Canada were diagnosed with prostate cancer, making it the most common cancer among Canadian men [1.4.5]. For those with advanced disease, a key question is: **how long can you stay on Orgovyx?** This is determined by efficacy and tolerability.

The FDA approved Orgovyx (relugolix) in 2020, introducing the first oral gonadotropin-releasing hormone (GnRH) antagonist for advanced prostate cancer. For patients seeking what is the alternative to Orgovyx, several other effective androgen-deprivation therapies are available, including injectable GnRH agonists and different types of hormone-targeting agents. These alternatives vary in their mechanism of action, administration route, side effects, and cost, making the choice a personalized decision based on a patient's health and treatment goals.

Clinical studies show ELIGARD (leuprolide acetate) is highly effective, with trials demonstrating that over 94% of patients achieve target testosterone suppression levels within a month of the first injection [2.3.1]. What is the success rate of ELIGARD? It is primarily measured by its ability to lower testosterone to castrate levels.

Prostate cancer affects about 1 in 8 men in the U.S., with hormone therapy being a cornerstone of treatment for advanced cases. A common question that arises for patients is, **is Eligard generic for Lupron?** While they share similarities, they are not identical.

Lupron (leuprolide acetate) is a hormone therapy used to treat advanced prostate cancer, endometriosis, and other conditions [1.8.1, 1.8.2]. A key question for many patients is, **can Lupron cause testicular pain**, and the answer is yes, particularly during the initial phase of treatment [1.2.2, 1.7.3].

According to Drugs.com, studies have shown that Eligard (leuprolide acetate) can maintain testosterone suppression for up to seven years. The optimal duration for how long can you stay on Eligard, however, is a complex decision made by a healthcare provider based on your specific prostate cancer stage, overall health, and response to therapy.

According to the National Cancer Institute, Orgovyx, also known by its generic name relugolix, is a drug used to treat adults with advanced prostate cancer. It represents the first oral gonadotropin-releasing hormone (GnRH) receptor antagonist for this condition, offering a new and convenient treatment approach.

Up to 90% of men receiving androgen deprivation therapy (ADT) for prostate cancer experience erectile dysfunction. Understanding if and how **can hormone therapy cause erectile dysfunction** is crucial for anyone undergoing or considering such treatments, as the effects vary significantly depending on the type and purpose of the therapy.